English to Russian Medical Medical: Pharmaceuticals Post-Marketing Experience, Periodic Safety Update Report

• Efficacy-Related Information: No new important information was received during the period of review involving relevant lack of efficacy that might represent a significant hazard to the treated population.

Late-Breaking Information: Since the data-lock point no new information that might affect the interpretation or evaluation of existing reports has come to our knowledge.

• Cumulative perspective: Non-Serious Unlisted Reactions: No non-serious unlisted reactions were reported during the period covered by this report.

• Increased Reporting Frequency of Listed Reactions:
No listed reactions were reported during the period covered by this report.